论文部分内容阅读
目的通过CAG联合诱导方案治疗难治性复发性急性髓系白血病患者,分析CAG联合诱导方案在临床的应用效果。方法对11例复发急性髓系白血病CAG预激方案诱导治疗及临床转归进行分析研究。结果11例复发急性髓系白血病,完全缓解6例占54.5%,部分缓解3例占27.3%,未缓解2例占18.2%。结论CAG方案对难治性复发性AML患者有积极的治疗作用,治疗过程中感染、出血等并发症少,无严重毒副作用和治疗相关死亡,是治疗难治性AML的有效治疗措施。
Objective To evaluate the clinical effect of CAG combined with induction regimen in the treatment of patients with refractory recurrent acute myeloid leukemia by CAG induction. Methods Eleven patients with recurrent acute myeloid leukemia CAG pre-induction regimen and clinical outcomes were analyzed. Results Of the 11 patients with recurrent acute myeloid leukemia, 6 patients (54.5%) were completely relieved, 3 (27.3%) partially relieved and 2 (18.2%) unresponsive. Conclusion The CAG regimen has a positive therapeutic effect on patients with refractory recurrent AML. There are few complications such as infection and bleeding during the course of CAG, and no serious side effects and treatment-related deaths. It is an effective treatment for refractory AML.